SAFLUTAN Trademark

Trademark Overview

On Friday, November 4, 2005, a trademark application was filed for SAFLUTAN with the United States Patent and Trademark Office. The USPTO has given the SAFLUTAN trademark a serial number of 79019110. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, July 27, 2014. This trademark is owned by SANTEN PHARMACEUTICAL CO., LTD.. The SAFLUTAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely ophthalmic preparations for the treatment of glaucoma
saflutan

General Information

Serial Number79019110
Word MarkSAFLUTAN
Filing DateFriday, November 4, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, July 27, 2014
Registration Number3194600
Registration DateTuesday, January 2, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely ophthalmic preparations for the treatment of glaucoma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 4, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Sharp & Dohme Corp.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889
Party NameMERCK & CO., INC.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressUS
Party NameSANTEN PHARMACEUTICAL CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka 5338651
JP
Party NameSANTEN PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka 5338651
JP
Party NameSANTEN PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 5338651
JP

Trademark Events

Event DateEvent Description
Friday, June 5, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Friday, February 13, 2015NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, February 13, 2015DEATH OF INTERNATIONAL REGISTRATION
Thursday, December 11, 2014GENERIC MADRID TRANSACTION SENT TO IB
Thursday, December 11, 2014GENERIC MADRID TRANSACTION CREATED
Wednesday, June 4, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, October 4, 2013CANCELLED SECTION 71
Saturday, July 10, 2010NEW REPRESENTATIVE AT IB RECEIVED
Monday, May 3, 2010REVIEW OF CORRESPONDENCE COMPLETE
Thursday, April 29, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 18, 2010CHANGE OF OWNER RECEIVED FROM IB
Monday, January 11, 2010PAPER RECEIVED
Friday, September 18, 2009CHANGE OF OWNER RECEIVED FROM IB
Friday, April 18, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 6, 2007FINAL DISPOSITION NOTICE SENT TO IB
Monday, August 6, 2007FINAL DISPOSITION PROCESSED
Wednesday, August 1, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 2, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, October 17, 2006PUBLISHED FOR OPPOSITION
Wednesday, September 27, 2006NOTICE OF PUBLICATION
Friday, September 1, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 25, 2006ASSIGNED TO LIE
Wednesday, August 23, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 23, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 26, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 26, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 26, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 8, 2006REFUSAL PROCESSED BY IB
Monday, May 22, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, May 22, 2006REFUSAL PROCESSED BY MPU
Thursday, May 18, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 17, 2006NON-FINAL ACTION WRITTEN
Tuesday, May 9, 2006ASSIGNED TO EXAMINER
Friday, January 6, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, January 5, 2006SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

saflutan preparations glaucoma treatment namely pharmaceutical ophthalmic